1Weir MR,Elkins M,Liss C,et al.Efficacy, tolerability and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension[].Clinical Therapeutics.1996 被引量：1
2Hansson L,Zanchetti A,Carruthers SG,et al.Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial[].The Lancet.1998 被引量：1
3Oparil S,Barr E,Elkins M,et al.Efficacy, tolerability and quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide in patients with essential hypertension[].Clinical Therapeutics.1996 被引量：1
4MacKay JH,Arcuri KE,Goldberg AI,et al.Losartan and low-dose hydrochlorothiazide in patients with essential hypertension[].Archives of Internal Medicine.1996 被引量：1
5Goa KL,Wagstaff AJ.Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension[].Drugs.1996 被引量：1
6Goldberg AI,Dunlay MC,Sweet CS.Safety and tolerability of losartan potassium, an angiotension Ⅱ receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension[].The American Journal of Cardiology.1995 被引量：1
